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Abstract
Background and Purpose
Treatment with triglyceride emulsions of docosahexaenoic acid (tri-DHA) protected neona-
tal mice against hypoxia-ischemia (HI) brain injury. The mechanism of this neuroprotection
remains unclear. We hypothesized that administration of tri-DHA enriches HI-brains with
DHA/DHAmetabolites. This reduces Ca2+-induced mitochondrial membrane permeabiliza-
tion and attenuates brain injury.
Methods
10-day-old C57BL/6J mice following HI-brain injury received tri-DHA, tri-EPA or vehicle. At
4–5 hours of reperfusion, mitochondrial fatty acid composition and Ca2+ buffering capacity
were analyzed. At 24 hours and at 8–9 weeks of recovery, oxidative injury, neurofunctional
and neuropathological outcomes were evaluated. In vitro, hyperoxia-induced mitochondrial
generation of reactive oxygen species (ROS) and Ca2+ buffering capacity were measured
in the presence or absence of DHA or EPA.
Results
Only post-treatment with tri-DHA reduced oxidative damage and improved short- and long-
term neurological outcomes. This was associated with increased content of DHA in brain
mitochondria and DHA-derived bioactive metabolites in cerebral tissue. After tri-DHA
administration HI mitochondria were resistant to Ca2+-induced membrane permeabilization.
In vitro, hyperoxia increased mitochondrial ROS production and reduced Ca2+ buffering
capacity; DHA, but not EPA, significantly attenuated these effects of hyperoxia.
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Conclusions
Post-treatment with tri-DHA resulted in significant accumulation of DHA and DHA derived bio-
active metabolites in the HI-brain. This was associated with improvedmitochondrial tolerance
to Ca2+-induced permeabilization, reduced oxidative brain injury and permanent neuroprotec-
tion. Interaction of DHA with mitochondria alters ROS release and improves Ca2+ buffering
capacity. This may account for neuroprotective action of post-HI administration of tri-DHA.
Introduction
Neonatal hypoxia-ischemia (HI) brain injury significantly contributes to neurological mortality
in children [1]. With a prevalence of 1 per 3500 live births, more than 25% of asphyxiated infants
develop life-long neurological impairments.1 Various mechanisms of neuronal damage following
HI have been proposed.[2–4]. Within minutes of acute oxygen and nutrient deprivation, early
energy failure initiates cellular dysfunction, which without reoxygenation/reperfusion, eventuates
in cellular death. Upon reperfusion, the bioenergetics of the post-ischemic tissue almost fully
recovers. However, over the next few hours, secondary energy failure takes place and drives the
evolution of necrosis and apoptosis [5,6] Mitochondrial dysfunction is knownmechanism of sec-
ondary energy failure [2,6] During reperfusion, mitochondria are overloaded with Ca2+. This
triggers the opening of permeability transition pores (mPTP) in the mitochondrial inner mem-
brane which arrests ATP production secondary to loss of the proton motive force and inhibition
of the respiratory chain [2] At the same time, BAX and other pro-apoptotic proteins permeabilize
the outer mitochondrial membrane, causing the release of apoptotic proteins [7]
N-3 polyunsaturated fatty acids (n-3 FAs) affect membrane composition and properties and have
the potential to enhance endogenous protective mechanisms attenuating brain injury [3]. In mouse
models of stroke, docosahexaenoic acid (DHA) and neuroprotectin D1 (NPD1), a bioactive deriva-
tive of DHA, significantly decreased brain tissue loss [8,9]. This neuroprotection was attributed to
anti-inflammatory actions of NPD1 and DHA. DHA concentrates in the membranes of brain grey
matter and increases membrane fluidity [10]. After ischemic stroke, DHA is liberated frommem-
brane phospholipids into the cytoplasm by phospholipase A2 and can be converted to NPD1 [11].
We recently reported that administration of n-3 TG enriched with both DHA and eicosa-
pentaenoic acid (EPA), immediately prior to and after HI, decreased brain injury in neonatal
mice [12] Furthermore, when we used only DHA- or only EPA-enriched TG emulsions (tri-
DHA or tri-EPA, respectively), only tri-DHA exerted neuroprotection[12]. It has also been
reported that DHA, but not EPA, increased the tolerance of myocardial mitochondria to Ca2+-
induced mPTP opening [13] We hypothesized that tri-DHA but not tri-EPA exerts long-term
or permanent neuroprotection since DHA, but not EPA, interacts with cerebral mitochondria.
We also hypothesized that DHA inhibits post-ischemic mPTP opening and therefore attenu-
ates secondary mitochondrial dysfunction. To test these hypotheses we compared the effects of
tri-DHA versus tri-EPA on brain mitochondria in the HI-reperfusion paradigm. By evaluation
of short- and long-term recovery, we also determined whether, in neonatal mice, acute post-
treatment with tri-DHA exerts permanent neuroprotection.
Materials & Methods
Lipid emulsions
We prepared VLDL-sized emulsions with TG oil containing either only DHA or only EPA and
egg yolk phospholipid, as previously detailed [12]. The emulsions were analyzed for the
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amount of TG and phospholipids (Wako Chemicals, Inc.). The TG: phospholipid mass ratio
was 5.0 ± 1.0, similar to that of VLDL-sized particles.
Unilateral cerebral hypoxia-ischemia injury
All studies were conducted according to protocols approved by the Columbia University Insti-
tutional Animal Care and Use Committee (IACUC) and in accordance with the AAALAC
guidelines. Three-day-old C57BL/6J neonatal mice with their dams were purchased from Jack-
son Laboratories (Bar Harbor). At 10 days of age (p10), mice were subjected to HI-insult as
previously described [12,14] Briefly, HI brain injury was induced by permanent ligation of the
right common carotid artery under 2% isoflurane anesthesia. After 1.5h of recovery, mice were
exposed to hypoxic (humidified 8% O2/ 92% N2, Tech Air Inc., NY) insult for 15 min, at 37±
0.3°C [12,14]
Treatment protocol
The doses (0.375 g n-3 TG/kg/dose) and the route of administration (intraperitoneum, IP)
were selected based on our previous work [12] The first dose was administered immediately
after HI and the second dose 1h after the first dose. Normal saline was used as vehicle (Veh).
Three groups were compared: HI+Veh; HI+tri-EPA; and HI+tri-DHA.
Neurofunctional outcomes
All neurofunctional outcomes were compared between study groups and naïve littermates.
Short-term neurofunctional outcomes were assessed at 24h after HI by evaluation of righting
reflex and negative geotaxis reflex performance, as previously detailed [14]. Not all mice were
assessed for neonatal reflex performance, because in one set of experiments neurofunctional
evaluation was missed.
Long-term neurofunctional outcome were defined by navigational memory performance in
the Morris water-maze test in adult mice (8 weeks after neonatal HI), as previously described
[15] Briefly, the landing platform (7.5 cm in diameter) was 0.5 cm submerged in one of four
quadrants in the pool with diameter 150 cm. For 3 consecutive days, animals were given three
attempts daily to learn to find the platform within 120 sec. The total latency time recorded over
three training days was used to assess navigational learning. On the day of navigational mem-
ory testing, the landing platform was removed and the time spent in the “landing” quadrant
was recorded (allotted time: 60 sec).
Neuropathological outcomes
At 24h of reperfusion, mice were sacrificed, brains were coronally sectioned and stained with
tri-phenyl-tetrazolium chloride (TTC). Infarcted area was traced in digital images using NIH-
image 4.1 and expressed as % of the ipsilateral hemisphere. Due to accidental loss of specimens
from the mice which were tested for navigational memory, long-term neuropathological out-
comes were assessed in a separate cohort of adult HI-mice at 8–9 weeks following HI. Brains
were coronally sectioned and Nissl-stained as previously described [16] The extent of injury
was defined by the % of residual brain tissue volume in the ipsilateral hemisphere in relation to
the contralateral hemisphere.
Assessment of DHA derived bioactive metabolites in brain tissue
To determine whether post-treatment with tri-DHA changes the content of DHA derived bio-
active metabolites, at two hours of reperfusion, cerebral concentrations of NPD1 and Resolvins
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D series (RvD1-6) were measured in HI-mice treated with tri-DHA or vehicle. All samples for
LC-MS-MS-based lipidomics were subject to solid-phase extraction as described [17] Prior to
sample extraction, d8-5-HETE, d5-RvD2, d5-LXA4, d4-LTB4, d4-PGE2 internal standards (500
pg each) were added to facilitate quantification. Extracted samples were analyzed by a liquid
chromatography-ultraviolet-tandem mass spectrometry system, QTrap 5500 (AB Sciex)
equipped with a Shimadzu LC-20AD HPLC (Tokyo, Japan). A Poroshell 120 EC-18 column
(100 mm × 4.6 mm × 2.7 μm; Agilent Technologies, Santa Clara, CA, USA) was kept in a col-
umn oven maintained at 50°C, and lipid mediators (LMs) were eluted with a gradient of meth-
anol/water/acetic acid from 55:45:0.01 (v/v/v) to 100:0:0.01 at 0.5 mL/min flow rate. To
monitor and quantify the levels of targeted LMs, multiple reaction monitoring (MRM) was
used with MS/MS matching signature ion fragments for each molecule (six diagnostic ions and
calibration curves). Concentrations of DHAmetabolites were expressed in pg/300 mg of brain
tissue.
In vitro studies
In vitro experiments determined whether DHA or EPA directly interacts with brain mitochon-
dria and alters mitochondrial response to oxidative stress. To mimic post-ischemic oxidative
stress associated with reintroduction of oxygen (reperfusion), mitochondria isolated from p10
mice were incubated in hyperoxic (paO2 470 mm Hg) buffer as described [6]. The rate of
mitochondrial reactive oxygen species (ROS) emission and mitochondrial Ca2+ buffering
capacity was assessed in the presence or absence of complexes; DHA: albumin (7:1 molar ratio)
or EPA:albumin (7:1 molar ratio) or DHA:albumin (molar ratio 1:1). In brief, 150 μM of DHA
or EPA in ethanol was mixed in 1% BSA or 0.147% BSA, which provided a FFA:albumin molar
ratio of 1:1 or 7:1, respectively. 100 μg of isolated mitochondria in 100 μl buffer was incubated
with 2 μl 0.15 mM DHA or EPA at different FFA:albumin molar ratios for 30 min in ice fol-
lowed by re-suspension in 1 ml buffer containing 0.2% BSA. For mitochondrial FA content
measurement samples were spun down (10,000 g, 10 min). For mitochondrial functional stud-
ies (ROS generation rate and Ca2+ buffering capacity) samples were free of re-suspension
buffer. DHA or EPA displacement from albumin and interaction with phospholipids differs
depending on the albumin:FFA molar ratio;17 therefore, albumin oversaturated with DHA or
EPA (7:1 ratio) would readily release FFA. In contrast, release of FFA from undersaturated
albumin (1:1 ratio) would be limited.
Assessments of mitochondrial function
Mitochondrial preparation. Mitochondrial functions were studied using ex-vivo isolated
brain mitochondria in HI+Veh, HI+tri-EPA or HI+tri-DHA mice and naïve littermates. At
4–5h of reperfusion (the time of secondary energy failure in this model),6 mice were euthanized
by decapitation and the ipsilateral hemispheres were homogenized in buffer (225 mMmanni-
tol, 75 mM sucrose, 1 mM EGTA, 5mMHEPES (pH 7.2), 1 mg/ml BSA). Mitochondria were
isolated as previously described [6].
Mitochondrial fatty acyl (FA) composition. At 4-5h of reperfusion, ex-vivo isolated brain
mitochondria and mitochondria in-vitro exposed to DHA:albumin or EPA:albumin complexes
were examined for their FA composition using gas chromatography (GC) according to the
method of Lepage and Roy [18]. Briefly, 1.5 ml of methanol-acetyl chloride (20:1, vol/vol) solu-
tion, 1.5 μl of butylated hydroxyl toluene (20 mM) and 95 μL of hexane were added to 75 μg of
mitochondrial proteins. The clear n-hexane top layer containing FA methyl esters (FAMEs)
was analyzed using a Hewlett-Packard 5890 Series II gas chromatograph. DHA content was
expressed as a percentage of total FA, identified by comparison with FA standards.
DHA Rescues Mitochondria after Hypoxia-Ischemia
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Mitochondrial ROS production was defined as the rate of H2O2 emission measured, as
described6, in isolated mitochondria. Briefly, 50 μg mitochondrial protein was incubated in 1
ml 10mM Tris-MOPS buffer, containing 5 mM succinate, 10 μMAmplex Ultrared (Invitro-
gen), and 4 U/ml horse radish peroxidase (HRP, Sigma). Changes in H2O2 fluorescence were
recorded using Hitachi 7000 spectrofluorimeter (555 nm excitation and 581 nm emission). The
rates of H2O2 emission were expressed in pmol H2O2/mg mitochondrial protein /min.
Mitochondrial calcium buffering capacity was measured as described [6]. Briefly, mitochon-
dria (50 μg protein/ml) in 10 mM Tris-MOPS buffer were supplemented with 10 μM 5N-cal-
cium green, 5mM succinate and 2.5 mM glutamate. Mitochondria were repeatedly
supplemented with 10 nmol CaCl2 every 50 sec until spontaneously released Ca
2+ indicated an
opening of the mPTP. The amount of calcium required for mPTP opening was expressed in
nmoles/mg mitochondrial protein.
Immunohistochemical assessment of oxidative brain injury
In experimental mice, brains were removed and coronal sections (20 μm) were incubated with
rabbit monoclonal antibody to 3-nitrotyrosine and to microtubule-associated protein 2
(MAP2) and Nissl for counterstain. Using Image Pro-Plus 4.5 (Media Cybernetics) the 3-nitro-
tyrosine immunoreactivity was analyzed by the count of immunopositive cells in 5 nonadjacent
fields (40X) of injured cortex at 3 different bregma levels. The mean ratio of immunopositive
cell / total number of cells per mouse was used for statistical analysis.
Statistical Analyses
Data are mean ± SEM. One-Way ANOVA followed by Fisher’s post-hoc analysis was used to
compare the differences in neurofunctional outcomes and mitochondrial functions among
naïve and experimental groups. Statistical significance was determined at p 0.05.
Results
Tri-DHA but not with tri-EPA exerts short- and long-term neuroprotection
At 24h of reperfusion only HI+tri-DHAmice exhibited a significant reduction in their cerebral
infarct volumes (Fig 1A and 1B). Fig Sensorimotor reflex performance was significantly poorer
in HI+Veh mice compared to naïves; both righting and negative geotaxis reflex performance was
sluggish (Fig 1C and 1D). Treatment with tri-DHA significantly improved righting reflex perfor-
mance compared to the HI+Veh littermates (Fig 1C). However, neither HI+tri-DHA nor HI+tri-
EPA resulted in significant improvement of negative geotaxis reflex performance (Fig 1D).
At 8–9 weeks after HI, compared to naïve littermates, adult HI+Veh mice exhibited significant
delays in locating a platform during spatial navigation training (Fig 2A). HI+tri-DHA or HI+tri-
EPAmice exhibited only a tendency toward improved spatial learning compared to HI+Veh litter-
mates (Fig 2A). However, navigational memory, which was significantly poorer in the HI+Vehmice
compared to naïve mice, was significantly improved only in HI+tri-DHAmice (Fig 2B),S1 Data.
Neuroanatomical analysis demonstrated a significantly greater preservation of the ipsilateral hemi-
sphere in the HI+tri-DHAmice compared to the HI+tri-EPA or HI+Veh group (Fig 2C and 2D).
Post-HI administration of tri-DHA increased DHA content and preserved
Ca2+ buffering capacity in cerebral mitochondria
Chronic dietary supplementation with n-3 FAs alters mitochondrial phospholipid FA composition
which may be beneficial in conditions such as HI [19]. We questioned whether neuroprotection
afforded by acute administration of tri-DHA is exerted through modulation of DHA content in
DHA Rescues Mitochondria after Hypoxia-Ischemia
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brain mitochondria following HI. Compared to naïve mice, the HI+Veh group did not show signif-
icant changes in DHA content in brain mitochondria (Fig 3A). As expected, HI+tri-EPA also did
not affect mitochondrial DHA content. However, HI+tri-DHA significantly increased mitochon-
drial DHA content (Fig 3A), the event associated with greater preservation of mitochondrial Ca2+
buffering capacity compared to HI+tri-EPA littermates (Fig 3B and 3C). There were no changes in
mitochondrial EPA content in the HI+tri-EPA group (data not shown).
Interaction of brain mitochondria with DHA increased mitochondrial DHA
content and improved Ca2+ buffering capacity impaired by oxidative
stress in vitro
To determine if DHA incorporates into mitochondria upon direct interaction, we incubated
cerebral mitochondria with a DHA:albumin complexes. At a DHA:albumin molar ratio of 1:1,
Fig 1. Short term neurological outcomes. (A) Infarct volumes in HI+Veh (n = 30), HI+tri-EPA (n = 20), or HI+tri-DHA (n = 20) mice. (B) Representative
TTC-stained cerebral sections from the same groups of mice. (C) Righting, and (D) Negative geotaxis reflex performance in naïve (n = 12); Veh+HI (n = 18);
HI+tri-EPA (n = 13); and HI+tri-DHA (n = 18) mice.
doi:10.1371/journal.pone.0160870.g001
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Fig 2. Long term neurological outcomes. (A) Cumulative latency time over 3 days of training and (B) Navigational memory
performance in Naive (n = 16); HI+Veh (n = 20); HI+tri-EPA (n = 16) and HI+tri-DHA (n = 22) adult mice. (C) and (D) Nissl-stained
cerebral coronal sections and residual ipsilateral hemisphere volume in the adult HI+Veh (n = 6), HI+EPA (n = 5) or HI+tri-DHA
(n = 5) mice.
doi:10.1371/journal.pone.0160870.g002
Fig 3. Mitochondrial DHA content and function following HI-insult. (A) Mitochondrial DHA content in Naïve (n = 8); Veh+HI (n = 11); HI+tri-EPA (n = 4);
and HI+tri-DHA (n = 12) mice. (B) and (C) Mitochondrial Ca2+ buffering capacity in Naïve (n = 7), HI+tri-EPA (n = 6) and HI+tri-DHA (n = 8) mice with
representative tracings. * p < 0.05 compared to naives.
doi:10.1371/journal.pone.0160870.g003
DHA Rescues Mitochondria after Hypoxia-Ischemia
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no mitochondrial DHA enrichment was detected (Fig 4A). However, when the DHA:albumin
molar ratio was increased to 7:1, mitochondrial DHA content increased significantly (Fig 4A).
Next we tested if mitochondrial DHA enrichment translates to functional benefits in organelles
exposed to oxidative stress in vitro. Hyperoxic exposure significantly reduced mitochondrial
tolerance to Ca2+-induced mPTP opening. Neither the presence of EPA:albumin 7:1, nor the
presence of DHA:albumin 1:1, preserved Ca2+ buffering capacity after hyperoxia induced dam-
age (Fig 4B–4D). Only exposure to DHA:albumin 7:1 significantly preserved Ca2+ buffering
Fig 4. Mitochondrial DHA content and function following hyperoxic stress in vitro. (A) Mitochondrial DHA content following in vitro incubation with Veh,
DHA:Alb 1:1, and DHA:Alb 7:1. * p < 0.05. (B) Mitochondrial Ca2+ buffering capacity: Normoxia, O2+Veh; O2 +DHA:Alb 1:1; and O2 +DHA:Alb 7:1. *
p 0.0005. (C) Mitochondrial Ca2+ buffering capacity in Normoxia; O2+Veh; O2 +EPA:Alb 7:1; and O2 +DHA:Alb 7:1. * p < 0.05. (D) Representative tracings
of mitochondrial Ca2+ buffering capacity. Groups are indicated. N = 4 in all groups.
doi:10.1371/journal.pone.0160870.g004
DHA Rescues Mitochondria after Hypoxia-Ischemia
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capacity, suggesting that, similar to our observations in vivo, increased mitochondrial DHA
content is linked to improved mitochondrial Ca2+ handling.
As well, hyperoxia dramatically increased mitochondrial H2O2 emission rates (Fig 5A and
5B). Following incubation with DHA:albumin 7:1, hyperoxic mitochondria significantly
(p = 0.01) reduced their H2O2 emission rate compared to the same mitochondria exposed to
O2 or O2+DHA:albumin 1:1 (Fig 5A and 5B). No effect on mitochondrial H2O2 generation
rate was detected in organelles incubated with EPA:albumin 7:1 (Fig 5A and 5B), S2 Data.
Tri-DHA but not tri-EPA attenuates oxidative brain injury following HI
insult
To translate our in vitro data into the in vivo model, we examined cerebral tissue for evidence
of oxidative damage in HI-mice. At 24h of reperfusion, HI+tri-DHA mice exhibited signifi-
cantly fewer cells immunopositive for 3-NT, a marker of protein oxidation, compared to the
HI+tri-EPA or HI+Veh groups (Fig 5C and 5D).
HI-mice treated with tri-DHA exhibited significant accumulation of DHA
derived bioactive metabolites in brain
At two hours of reperfusion (one hour following a completion of tri-DHA treatment), we
found significantly greater accumulation of DHA derived bioactive metabolites, NPD1, and all
RvD series in the ipsilateral hemisphere compared to that in the vehicle-treated littermates (Fig
6A), S3 Data. Fig 6B shows the NPD1 and all six RvD spectra obtained from brains of vehicle
and tri-DHA treated HI-mice which were used to determine their concentrations. There was a
tendency for increase in these DHA derivatives in the contralateral unaffected hemisphere sug-
gesting that increases in these compounds might in part relate to a “systemic” release from
exogenous DHA. Of note, in the HI-mice treated with tri-DHA, accumulation of some DHA
derived bioactive metabolites (RvD3, RvD5) was significantly greater in the ipsilateral, ischemic
hemisphere compared to that in the contralateral, unaffected hemisphere (Fig 6A).
Discussion
Our study provides original in vivo and in vitro evidence for (a) permanent neurological benefits
and (b) mitochondria-associated mechanisms of neuroprotection afforded by post-treatment with
tri-DHA after HI brain injury in neonatal mice. We show that, during evolution of reperfusion
injury, administration of tri-DHA was coupled with increased DHA content in brain mitochon-
dria, the event associated with preservation of mitochondrial tolerance to Ca2+-induced permeabi-
lization. We also demonstrate significant accumulation of DHA derived bioactive metabolites in
the HI-affected brains in mice treated with tri-DHA. This suggests that exogenous DHA and its
metabolites are transferred to, and accumulate in HI-affected brain tissue and mitochondria,
modifying mitochondrial membrane response to Ca2+ overload. Our in vitro experiments demon-
strate that direct interaction of DHA with mitochondria diminished hyperoxia-induced surge in
mitochondrial ROS production and preserved mitochondrial Ca2+ buffering capacity.
We have reported that tri-DHA significantly reduced brain injury assessed at 24h and 8
weeks after HI [12]. However, it was not determined whether this reduction in the extent of
injury translates into long-term neurofunctional benefits. We extended our observational strat-
egy by assessment of long-term neurofunctional outcomes in HI-mice treated with tri-DHA or
tri-EPA. Our study showed that only DHA but not EPA exerted permanent long term neuro-
protection, as evidenced by the reduced anatomical extent of injury and by better preservation
of navigational memory in adulthood. In models of stroke and myocardial infarction in mature
DHA Rescues Mitochondria after Hypoxia-Ischemia
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rodents, DHA also conferred better organ protection than EPA [19,20]. Pan et al. found that
pre-treatment with DHA for 6 weeks prior to HI insult significantly attenuated brain injury
[20].In the neonatal rat model of HI brain injury, pre-treatment with albumin-complexed
DHA improved neurofunctional recovery, although no neuroanatomically-identifiable benefit
was detected [21]. In the same model, DHA:albumin complexes markedly augmented the neu-
roprotective effects of hypothermia [22]. Thus, our data are in agreement with other reports on
neuroprotective actions of DHA in the setting of perinatal HI-brain injury.
The mammalian central nervous system contains relatively high levels of DHA but very low
levels of EPA [23]. This suggests that in the brain, EPA might be a precursor of DHA synthe-
sis.3 Daily EPA IP injection for one week conferred neuroprotection in a model of transient
bilateral carotid artery occlusion [24]. Chronic EPA administration for 4 weeks improved
memory function and decreased neuronal loss in the same rodent model [24]. Perhaps delayed
tissue distribution of EPA associated with chronic administration is required to achieve benefi-
cial effects against cerebral ischemia. However, in the setting of acute treatment, tri-EPA does
not affect the propagation of HI brain injury.
Alterations of FA levels in plasma membranes change fluidity, altering the function of mem-
brane-associated proteins [19,25]. Dietary supplementation of n-3 FAs increased mitochon-
drial content of DHA and EPA in cardiac tissues [19]. Importantly, only changes in
mitochondrial DHA but not EPA were associated with significantly greater Ca2+ buffering
capacity in cardiac mitochondria [19]. In our study, post-HI administration of DHA also sig-
nificantly increased mitochondrial DHA content assessed at the time when secondary energy
failure takes place in this model.6 Only DHA-enriched brain mitochondria exhibited improved
tolerance to Ca2+-induced membrane permeabilization. Post-ischemic Ca2+-induced permea-
bilization of mitochondrial membranes is currently viewed as the mechanism of secondary
energy failure [6,26,27]. Our data suggest that post-HI enrichment of cerebral mitochondria
with DHAmay account for the attenuation of the severity of secondary energy failure, as
DHA-enriched organelles were more resistant to Ca2+-induced mitochondrial permeabiliza-
tion. Our in vitro data supports this point, since incubation of cerebral mitochondria with
DHA-saturating albumin complexes significantly increased DHA content in these organelles.
This effect was translated into significantly greater preservation of mitochondrial Ca2+ buffer-
ing capacity which was markedly altered by hyperoxic stress. Another potential neuroprotec-
tive mechanism of post-HI tri-DHA administration may be exerted by DHA derived bioactive
metabolites, such as NPD1 and/or the RvD family. This hypothesis is supported by our results,
demonstrating a significant accumulation of these metabolites in the HI-affected brains follow-
ing treatment with tri-DHA. Our data provide an important rationale for future studies in test-
ing potential neuroprotective actions and mechanisms related to a number of DHA-
derivatives. While neuroprotective properties of NPD1 in murine models of focal stroke has
been reported [8], our data on the robust elevations of RvD compounds in the ipsilateral hemi-
sphere now highlight potential neuroprotective effects of these DHAmetabolites. It has been
shown, that RvD2, RvD3 and RvD4 exert strong anti-inflammatory actions [28,29], protecting
murine lungs against ischemia-reperfusion injury [30].
Oxidative stress plays a key mechanistic role in reperfusion injury and, in particular, induc-
tion of secondary brain injury [2,6,31,32] By mimicking hyperoxic re-oxygenation/reperfusion,
our in vitro paradigm demonstrated that cerebral mitochondria dramatically accelerate
Fig 5. Mitochondrial production of ROS in vitro andmarkers for oxidative brain injury in vivo. (A) Mitochondrial H2O2 emission rates in
Normox; O2+Veh; O2 +DHA:Alb 7:1; O2 +DHA:Alb 1:1; and O2 +EPA:Alb 7:1. N = 5 in all groups (B) Representative tracing of mitochondrial H2O2
production (groups are indicated). (C) 3-nitrotyrosine immunopositive cells / total cells ratio in HI+Veh, HI+EPA and HI+DHA. N = 4 in all groups. *
p = 0.02. (D) Representative images of 3-nitrotyrosine staining in HI+Veh, HI+EPA and HI+DHAmice.
doi:10.1371/journal.pone.0160870.g005
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generation of ROS known to cause oxidative injury to the post-ischemic brain and other tissues
[2,6,33]. The same experiment showed that enrichment of mitochondria with DHA signifi-
cantly limited hyperoxia-induced increases in mitochondrial ROS production. These in vitro
data suggest a potential mechanism underlying the neuroprotective effects of acute tri-DHA
post-treatment in vivo—exogenous DHA incorporates into post-HI mitochondria, and this
limits a reperfusion-driven acceleration in mitochondrial ROS release, and attenuates the oxi-
dative injury which sensitizes mitochondria to Ca2+-mPTP. This potential sequence of events
is supported by significant attenuation of oxidative brain damage in HI+tri-DHA mice com-
pared to their HI+tri-EPA treated littermates.
A limitation of our study is the absence of direct evidence for the exogenous origin of mito-
chondrial DHA-enrichment following post-treatment with tri-DHA. Therefore, our data can
only suggest that mitochondrial enrichment with DHA in vivo was due to administration of
exogenous tri-DHA. However, our in vitro experiments clearly demonstrate that upon interac-
tion of mitochondria, the DHA incorporates into organelles and this improves mitochondrial
abilities to buffer excess of Ca2+. The specificity of DHA-mitochondria interaction in this effect
is supported by unchanged mitochondrial phenotypes when the same dose of DHA was used
but at DHA:albumin molar ratio of 1:1. Finally, significant elevation of DHA derived bioactive
metabolites t in the brains of only DHA-treated HI-mice strongly supports exogenous origin of
the DHA and its derivatives in the affected tissue.
Another limitation is that we did not explore all potential therapeutic mechanisms of DHA.
It is possible that other reported mechanisms of post-HI neurodegeneration, glutamate excito-
toxicity, neuroinflammation and BAX induced apoptosis are affected by DHA and/or biologi-
cally active DHAmetabolites. We believe that these limitations do not reduce the significance
of our work which is the first to demonstrate the permanent nature of DHA-driven neuropro-
tection with an emphasis on post-ischemic mitochondria as the main therapeutic target. Thus,
acute post-treatment with tri-DHA, and DHA derived bioactive metabolites (NPD1, RvDs)
should be considered for future research on the translation of this very promising neuroprotec-
tive strategy into clinical practice.
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